Bruno Sepodes

Chair of the Committee of Medicinal Products for Human Use (European Medicines Agency) | Full Professor (University of Lisbon, Portugal)

Lisbon, Lisbon, Portugal

About

Bruno Sepodes is a Full Professor of Pharmacological Sciences at the Faculty of Pharmacy of the University of Lisbon (Portugal). He is a Pharmacist (holding a PharmD), holds an MSc in Pharmaceutical Regulatory Science, a PhD in Pharmacology and Habilitation in Pharmacology and Pharmacotherapy, all by the University of Lisbon. Bruno also holds a MPH degree from the Bloomberg School of Public Health of the Johns Hopkins University (USA). Besides being Senior Non-Clinical and Clinical Expert for INFARMED (the Portuguese National Authority for Medicines and Health Products), he became a member of the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) in 2008 and served for two mandates as Chairperson of this Committee (2012-2018). Additionally, Bruno is also member of the European Medicines Agency’s (EMA) Committee for Human Medicinal Products (CHMP, since 2012) and was a member of the Committee of Advanced Therapies (CAT, 2013-2024). In 2024 Bruno Sepodes became Chair of the Committee of Human Medicinal Products (CHMP), following two mandates as Vice-Chair of the committee (2018-2024). During 2020 Bruno became member of the EMA Emergency Task Force (ETF), representing CHMP in the efforts to deal with the challenges of COVID-19 pandemic therapeutics and vaccines, and, in 2022, with the extension of mandate of EMA and formal implementation of ETF as a constant working force of the Agency, Bruno became Co-Chair of the EMA Emergency Task Force. In 2018 he received the “EURORDIS Leadership Black Pearl Award” on Rare Diseases, attributed to an individual who has demonstrated remarkable leadership in the field of rare diseases at a European level. Bruno received 15 national and international scientific awards and was on the top 100 inspirational industry professionals of “The Medicine Maker Power List 2018”, under the category ‘Masters of Change’ for year 2018. Bruno Sepodes is author and co-author of several scientific publications in international journals and presented to national and international scientific meetings.

Experience

  • European Medicines Agency (17 yrs 11 mos)
    • Chair of the Committee of Medicinal Products for Human Use (CHMP)
      Sep 2024 - Present · 1 yr 11 mos

    • Co-Chair of the Emergency Task Force (ETF)
      Apr 2022 - Present · 4 yrs 4 mos

    • Member of the Scientific Coordination Board
      Apr 2022 - Present · 4 yrs 4 mos

  • ICH Assembly Member (European Commission, EUROPE) at International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    Nov 2021 - Present · 4 yrs 9 mos

  • Faculty of Pharmacy of the University of Lisbon ()
    • Full Professor of Pharmacological Sciences
      Dec 2021 - Present · 4 yrs 8 mos

      Pharmacology, Pharmacotherapy and Pharmaceutical Regulatory Science

    • Associate Professor with Habilitation
      Oct 2020 - Dec 2021 · 1 yr 3 mos

      Pharmacology, Pharmacotherapy and Pharmaceutical Regulatory Science

  • Honorary Senior Lecturer at Queen Mary University of London
    Jun 2021 - Present · 5 yrs 2 mos

    Honorary Senior Lecturer in the Centre for Translational Medicine & Therapeutics within William Harvey Research Institute.

  • Ordem dos Farmacêuticos (9 yrs 5 mos)
    • Member of the Council for Qualification and Admission (CQA)
      Mar 2017 - Present · 9 yrs 5 mos

    • President of the National Fiscal Board
      Mar 2019 - Feb 2022 · 3 yrs

    • President of the Regional Fiscal Board (North Region)
      Mar 2019 - Feb 2022 · 3 yrs